Novartis AG (NOVNEE)
SIX
Real-time Data
07:00 AM
Day's Range
125.1052 wk Range
96.15Overview - NOVNEE - Novartis AG
Key Statistics
Valuation
Enterprise Value
228.07B
P/E (Trailing)
‪22.69‬
Price / Sales (TTM)
‪4.38‬
Price / Book
‪7.13‬
EV / EBITDA
‪12.32‬
Profitability
Gross Margin
‪75.18%‬
Profit Margin
‪22.50%‬
Operating Margin
‪34.62%‬
Return on Assets
‪10.25%‬
Return on Equity
‪30.35%‬
Ownership
Shares Outstanding
1.90B
Float
1.85B
Price stats
Beta
‪0.49‬
50-Day Avg
‪125.18‬
200-Day Avg
‪121.52‬
Market Cap - NOVNEE - Novartis AG
Peers - NOVNEE - Novartis AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on SIX.
- NOVNEESIXNovartis AG248.37BMarket Cap+20.72%52-week change22.70P/E (Trailing)‪22.50%‬Profit Margin
- LLYSIXEli Lilly and Company900.27BMarket Cap+44.06%52-week change41.32P/E (Trailing)‪33.52%‬Profit Margin
- JNJSIXJohnson & Johnson527.16BMarket Cap+21.06%52-week change29.18P/E (Trailing)‪21.48%‬Profit Margin
- ROSIXRoche Holding AG302.45BMarket Cap+28.35%52-week change24.75P/E (Trailing)‪19.60%‬Profit Margin
- MRKSIXMerck & Co., Inc.284.44BMarket Cap+32.03%52-week change32.58P/E (Trailing)‪13.58%‬Profit Margin
- GILDSIXGilead Sciences Inc.145.04BMarket Cap+11.46%52-week change18.69P/E (Trailing)‪-10.63%‬Profit Margin
- PFESIXPfizer Inc.128.24BMarket Cap+8.04%52-week change36.29P/E (Trailing)‪6.80%‬Profit Margin
Profile Summary - NOVNEE - Novartis AG
About
Novartis AG is a global healthcare company based in Switzerland, specializing in the research and development of pharmaceutical products. Functioning at the forefront of the medical innovation landscape, Novartis is dedicated to discovering new ways to improve and extend people’s lives. The company is predominantly…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
